Skip to main content
Log in

Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil

  • Case Reports
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Pseudomembranous colitis is frequently associated with antibiotics and more rarely with chemotherapeutic agents such as 5-fluorouracil. The objective of this study is to show that it is possible to confuse this infection with chemotherapy associated toxicity. We present a 54 year old woman who underwent surgery for colorectal cancer and in the first cycle of chemotherapy with 5-fluorouracil developed pseudomembranous colitis. We detected the toxin B ofClostridium difficile in stools and we began early antibiotic treatment. Thus, in patients with post chemotherapy neutropenia and diarrhoea that develop negatively, we have to rule out this infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Trevisani F, Simoncini M, Alampi G, et al. Colitis associated to chemotherapy with 5-fluorouracil. Hepatogastroenterology. 1997;44:710–2.

    PubMed  CAS  Google Scholar 

  2. Gardiner SJ, Begg EJ, Robinson BA. The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil. Adverse Drug React Toxicol Rev. 2002;21(1–2):1–16.

    PubMed  CAS  Google Scholar 

  3. Van Kuilenburg AB, Meinsma R, Zoetekouw L, et al. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropirymidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation. Int J Cancer. 2002;101:253–8.

    Article  PubMed  CAS  Google Scholar 

  4. Van Kuilenburg AB, De Abreu RA, van Gennip AH. Pharmacogenetic and clinical aspects of dihydropirymidine dehydrogenase deficiency. Ann Clin Biochem. 2003;40(Pt 1):41–5.

    Article  PubMed  Google Scholar 

  5. Mattison LK, Soong R, Diasio RB. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics. Pharmacogenomics. 2002;3(4):485–92.

    Article  PubMed  CAS  Google Scholar 

  6. Fiumara A, van Kuilenburg AB, Caruso U, et al. Dihydropyrimidine dehydrogenase deficiency and acute neurological presentation. J Inherit Metab Dis. 2003; 26(4):407–9.

    Article  PubMed  CAS  Google Scholar 

  7. Van Kuilenburg AB, Haasjer J, Van Lenthe H, et al. Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity. Adv Exp Med Biol. 2000;486:251–5.

    Article  PubMed  Google Scholar 

  8. Van Kuilenburg AB, Haasjes J, Richel DJ, et al. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. clin Cancer Res. 2000;6(12):4705–12.

    PubMed  Google Scholar 

  9. Wilcox M.Clostridium difficile infection and pseudo-membranous colitis. Best Pract Res Clin Gastroenterol. 2003;17(3):475–93.

    Article  PubMed  Google Scholar 

  10. Portillo-López MI, Castellanos-Urdaibay MA, Cortés-Nava E, et al.clostridium difficile infection. Gac Med Mex. 2002;138(1):57–66.

    PubMed  Google Scholar 

  11. Klingler PJ, Metzger PP, Seelig MH, et al.Clostridium difficile infection: risk factors, medical and surgical management. Dig Dis. 2000;18:147–60.

    Article  PubMed  CAS  Google Scholar 

  12. Brar HS, Surawicz CM. Pseudomembranous colitis: an update. Can J Gastroenterol. 2000;22(1):51–6.

    Google Scholar 

  13. Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Safety. 2000;22(1):53–72.

    Article  PubMed  CAS  Google Scholar 

  14. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin forclostridium difficile associated diarrhoea and colitis. Lanced. 1983;2:1043–6.

    Article  CAS  Google Scholar 

  15. Bavaro M. Neutropenic enterocolitis. Curr Gastroenterol Rep. 2002;4(4):297–301.

    Article  PubMed  Google Scholar 

  16. King N. Nursing care of the child with neutropenic enterocolitis. J Pediatr Oncol Nurs. 2002;19(6):198–204.

    Article  PubMed  Google Scholar 

  17. Rodríguez Cerrillo M, Nieto Sánchez A, et al. Diagnosis of ischaemic colitis in a emergency department. Emergencias. 2000;12:100–4.

    Google Scholar 

  18. MacDonald P. Ischaemic colitis. Best Pract Res Clin Gastroenterol. 2002;16(1):51–61.

    Article  PubMed  CAS  Google Scholar 

  19. Brandt L, Boley SJ. Colonic ischemia. Surg clin North Am. 1992;72:203–30.

    PubMed  CAS  Google Scholar 

  20. Kolkman JJ, Mensink PB. Non-occlusive mesenteric ischaemia: a common disorder in gastroenterology and intensive care. Best Pract Res Clin Gastroenterol. 2003;17(3):457–73.

    Article  PubMed  Google Scholar 

  21. Perez CA, Brady L. Principles and practice of radiation oncology. 3a ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1998.

    Google Scholar 

  22. Kinsella TJ, Bloomer WD. Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet. 1980;151(2):273–84.

    PubMed  CAS  Google Scholar 

  23. Galland RB, Spencer J. Surgical management of radiation enteritis. Surgery. 1986;99(2):133–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rafael Morales Chamorro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamorro, R.M., Blanch, R.S., Vidal, M.J.M. et al. Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil. Clin Transl Oncol 7, 258–261 (2005). https://doi.org/10.1007/BF02710173

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02710173

Key words

Navigation